Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Spruce Biosciences (SPRB) EBIT Margin (2023 - 2024)

Spruce Biosciences (SPRB) has disclosed EBIT Margin for 2 consecutive years, with 3385.94% as the latest value for Q4 2024.

  • On a quarterly basis, EBIT Margin fell 299924.0% to 3385.94% in Q4 2024 year-over-year; TTM through Sep 2025 was 6960.2%, a 635005.0% decrease, with the full-year FY2024 number at 1143.37%, down 62803.0% from a year prior.
  • EBIT Margin was 3385.94% for Q4 2024 at Spruce Biosciences, down from 1568.0% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 386.7% in Q4 2023 to a low of 3385.94% in Q4 2024.